326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma

Bibliographic Details
Main Authors: Yuting Zhang, Jincai Zhou, Zhongjun Shi, Feifei Shi, Siye Chen, Chenyu Huang, Huijiao Li, Ruirong Yi, Huajing Wang, Xian-Yang Li, Xiaowen He
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797634995840352256
author Yuting Zhang
Jincai Zhou
Zhongjun Shi
Feifei Shi
Siye Chen
Chenyu Huang
Huijiao Li
Ruirong Yi
Huajing Wang
Xian-Yang Li
Xiaowen He
author_facet Yuting Zhang
Jincai Zhou
Zhongjun Shi
Feifei Shi
Siye Chen
Chenyu Huang
Huijiao Li
Ruirong Yi
Huajing Wang
Xian-Yang Li
Xiaowen He
author_sort Yuting Zhang
collection DOAJ
first_indexed 2024-03-11T12:16:06Z
format Article
id doaj.art-ced11fc7956f4911ba1d5d4c5496c200
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T12:16:06Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-ced11fc7956f4911ba1d5d4c5496c2002023-11-07T09:35:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0326326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myelomaYuting Zhang0Jincai Zhou1Zhongjun Shi2Feifei Shi3Siye Chen4Chenyu Huang5Huijiao Li6Ruirong Yi7Huajing Wang8Xian-Yang Li9Xiaowen He10Oricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, ChinaOricell Therapeutics, Shanghai, China
spellingShingle Yuting Zhang
Jincai Zhou
Zhongjun Shi
Feifei Shi
Siye Chen
Chenyu Huang
Huijiao Li
Ruirong Yi
Huajing Wang
Xian-Yang Li
Xiaowen He
326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
Journal for ImmunoTherapy of Cancer
title 326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
title_full 326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
title_fullStr 326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
title_full_unstemmed 326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
title_short 326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
title_sort 326 optimization of gprc5d targeted car t cells oricar 017 for multiple myeloma
work_keys_str_mv AT yutingzhang 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT jincaizhou 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT zhongjunshi 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT feifeishi 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT siyechen 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT chenyuhuang 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT huijiaoli 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT ruirongyi 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT huajingwang 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT xianyangli 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma
AT xiaowenhe 326optimizationofgprc5dtargetedcartcellsoricar017formultiplemyeloma